The Cole Eye Institute Imaging Summit took place on Friday, August 9, 2016 prior to the American Society of Retina Specialists (ASRS).

The is a CME symposium focusing on new advances in OCT imaging with hands-on imaging sessions. Attendees will be able to discuss current topics in tomography and imaging with a faculty of distinguished peers. Ocular imaging technology is an area of intense innovation with every year bringing better and more options to the clinic. Outcomes in vision care are best when ophthalmologists, retina specialists, and other eye care health practicioners remain informed of the latest ocular imaging capabilities. Following this course, learners will be able to better select appropriate diagnostic testing and better interpret those tests to improve patient care. Additionally, learners will be made aware of new and exciting modalities of ophthalmic imaging that can be implemented into their clinical practice.

Session Topics

  • Diagnostic Imaging Approaches for Posterior Uveitis – Glenn Jaffe, MD
  • Utilizing Quantitative Imaging for Ongoing Uveitis Management – Sunil K. Srivastava, MD
  • Advanced Imaging of the White Dot Syndromes Including MEWDS & PRD – David Sarraf, MD

Imaging Approaches in Diagnostic Dilemmas and Uveitis

  • Diagnostic Imaging Approaches for Posterior Uveitis

    Glenn Jaffe; Sunil K. Srivastava, and David Sarraf
Target Audience

This activity is designed to meet the educational needs of Physicians (eg, Comprehensive Ophthalmologists, Retina Specialists, and Optometrists), Second-Year Fellows, Technicians, Ophthalmic Photographers and other healthcare professionals.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Discuss the mechanisms of disease development in MEWDS and placoid disorders using advanced retinal imaging.
  • Describe the different imaging methods for specific uveitic conditions.
  • Explain how to use a tailored multimodal approach to posterior uveitis diagnosis.
Method of Participation

Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claimed credit form available at

Please claim your credit by September 23, 2017.

If you have questions about this CME activity, please contact AKH Inc. at


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support

This activity is supported by an educational grant from: Alcon, Inc.; Bayer; Regeneron Pharmaceuticals, Inc.; Santen Pharmaceutical


It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.


Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Planner Disclosures

Glenn J. Jaffe, MD

  • Consultant: Heidelberg Engineering GmbH

David Sarraf, MD

  • Consultant: Genentech, Inc.; Optovue, Inc
  • Contracted Research: Allergan; Genentech, Inc.; Optovue, Inc; Regeneron Pharmaceuticals, Inc.

Sunil K. Srivastava, MD

  • Allergan; Bausch + Lomb; Carl Zeiss Meditec, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; Santen Pharmaceutical
Planner Disclosures

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditations

  • Nothing to Disclose

MCME Global Staff and Planners

  • Nothing to Disclose

AKH Staff and Planners

  • Nothing to Disclose

Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc.

Advancing Knowledge in Healthcare    mcme-logo



Please answer the following pre-questions before moving on to the session presentations.

First Name*
Last Name*

Fluorescein angiography to image uveitis patients:

Is no longer needed with the advent of OCT Angiography
Is helpful to diagnose placoid syphilitic uveitis
Is needed to diagnose uveitic cystoid macular edema
Has a similar early and late pattern in the white dot syndromes

ICG angiography

Shows hyperfluorescent spots in eyes with MEWDS, birdshot retinochoroidopathy, and multifocal choroiditis and panuveitis
Shows focal hyperfluorescent choroidal spots in VKH
Shows choroidal vascular leakage in VKH
Shows hyperfluorescent spots in AMPPE